Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dose Optimization of Sotorasib: Is the US Food and Drug Administration Sending a Message?

× No keyword cloud information.

5 in total

1. Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).

Authors: Anne L Loeser; Lucy Gao; Aditya Bardia; Mark E Burkard; Kevin M Kalinsky; Jeffrey Peppercorn; Hope S Rugo; Martha Carlson; Janice Cowden; Lesley Glenn; Julia Maues; Sheila McGlown; Andy Ni; Natalia Padron; Maryam Lustberg
Journal: Breast Cancer Res Treat Date: 2022-10-06 Impact factor: 4.624

2. FDA initiatives to support dose optimization in oncology drug development: the less may be the better.

Authors: Hanlim Moon
Journal: Transl Clin Pharmacol Date: 2022-06-22

3. Stopping rules for phase I clinical trials with dose expansion cohorts.

Authors: Sean M Devlin; Alexia Iasonos; John O'Quigley
Journal: Stat Methods Med Res Date: 2021-12-24 Impact factor: 2.494

4. Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer.

Authors: Stefanie D Krens; Nielka P van Erp; Stefanie L Groenland; Dirk Jan A R Moes; Sasja F Mulder; Ingrid M E Desar; Tom van der Hulle; Neeltje Steeghs; Carla M L van Herpen
Journal: BMC Cancer Date: 2022-03-02 Impact factor: 4.430

5. Dose Finding in Oncology: What is Impeding Coming of Age?

Authors: Kapil Mayawala; Dinesh de Alwis
Journal: Pharm Res Date: 2022-04-26 Impact factor: 4.580

5 in total